Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Arnold

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Wellcome Open Research|January 18, 2021
Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK BiobankNaomi E Allen, Matthew Arnold, Sarah Parish, et al.
Journal of Neurointerventional Surgery|April 9, 2026
Incidence and risk factors for delayed structural changes in Pipeline Embolization DevicesClint Badger, Souvik Singha, Huanwen Chen, et al.
BMJ Public Health|April 1, 2025
Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking studyZander Gu, Francesca Gasperoni, Ellie Paige, et al.
BMJ Open|May 22, 2023
Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD studyNavdeep Tangri, Toshiki Moriyama, Markus P Schneider, et al.
JAMA Network Open|March 2, 2019
Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical TrialsAlison Offer, Matthew Arnold, Robert Clarke, et al.
Vaccine|August 21, 2022
Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associationsMichael A Laffan, Sue Rees, Madhavi Yadavalli, et al.
Clinical Kidney Journal|November 3, 2022
Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohortCarol Pollock, Glen James, Juan Jose Garcia Sanchez, et al.
Kidney International Reports|April 18, 2023
Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective CohortJuan Jose Garcia Sanchez, Glen James, Juan Jesus Carrero, et al.
Plos One|September 29, 2023
Prioritising cardiovascular disease risk assessment to high risk individuals based on primary care recordsRyan Chung, Zhe Xu, Matthew Arnold, et al.
European Journal of Preventive Cardiology|January 28, 2017
Burden of carotid artery atherosclerosis in Chinese adults: Implications for future risk of cardiovascular diseasesRobert Clarke, Huaidong Du, Om Kurmi, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Wellcome Open Research|January 18, 2021
Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK BiobankNaomi E Allen, Matthew Arnold, Sarah Parish, et al.
Journal of Neurointerventional Surgery|April 9, 2026
Incidence and risk factors for delayed structural changes in Pipeline Embolization DevicesClint Badger, Souvik Singha, Huanwen Chen, et al.
BMJ Public Health|April 1, 2025
Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking studyZander Gu, Francesca Gasperoni, Ellie Paige, et al.
BMJ Open|May 22, 2023
Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD studyNavdeep Tangri, Toshiki Moriyama, Markus P Schneider, et al.
JAMA Network Open|March 2, 2019
Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical TrialsAlison Offer, Matthew Arnold, Robert Clarke, et al.
Vaccine|August 21, 2022
Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associationsMichael A Laffan, Sue Rees, Madhavi Yadavalli, et al.
Clinical Kidney Journal|November 3, 2022
Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohortCarol Pollock, Glen James, Juan Jose Garcia Sanchez, et al.
Kidney International Reports|April 18, 2023
Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective CohortJuan Jose Garcia Sanchez, Glen James, Juan Jesus Carrero, et al.
Plos One|September 29, 2023
Prioritising cardiovascular disease risk assessment to high risk individuals based on primary care recordsRyan Chung, Zhe Xu, Matthew Arnold, et al.
European Journal of Preventive Cardiology|January 28, 2017
Burden of carotid artery atherosclerosis in Chinese adults: Implications for future risk of cardiovascular diseasesRobert Clarke, Huaidong Du, Om Kurmi, et al.
Pageof 7